Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE
NCT07233642
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Systemic Lupus Erythematosus
Interventions
BIOLOGICAL:
CD19 CAR-T cells
Sponsor
The Children's Hospital of Zhejiang University School of Medicine